| http://www.w3.org/ns/prov#value | - Making drugs from previously unexplored types of chemicals increases the chances of problematic side effects, explains John F. Niblack, R&D chief at Pfizer Inc. (PFE) And new targets that look great in the test tube or in animals often do not pan out in humans.
|
